Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 IgA nephropathy: recent developments.

Literature DB >> 11095664

IgA nephropathy: recent developments.

Jürgen Floege¹, John Feehally².

Abstract

Entities: Disease

Mesh：

Year: 2000 PMID： 11095664 DOI： 10.1681/ASN.V11122395

Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121

Keyword Cloud
Cited

× No keyword cloud information.

41 in total

Review 1. Progress in molecular and genetic studies of IgA nephropathy.

Authors: J Novak; B A Julian; M Tomana; J Mesteck
Journal: J Clin Immunol Date: 2001-09 Impact factor: 8.317

2. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.

Authors: L-L Liu; Y Jiang; L-N Wang; N Liu
Journal: Clin Exp Immunol Date: 2012-08 Impact factor: 4.330

3. High-dose intravenous immunoglobulin pulse therapy in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.

Authors: F M Rasche; F Keller; P M Lepper; C Aymanns; W Karges; L-C Sailer; L von Müller; D Czock
Journal: Clin Exp Immunol Date: 2006-10 Impact factor: 4.330

4. Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice.

Authors: Toshikazu Nishie; Osamu Miyaishi; Haruhito Azuma; Akihiko Kameyama; Chie Naruse; Noriyoshi Hashimoto; Hitoshi Yokoyama; Hisashi Narimatsu; Takashi Wada; Masahide Asano
Journal: Am J Pathol Date: 2007-02 Impact factor: 4.307

5. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

Authors: Azusa Hashimoto; Yusuke Suzuki; Hitoshi Suzuki; Isao Ohsawa; Rhubell Brown; Stacy Hall; Yuichi Tanaka; Jan Novak; Hiroyuki Ohi; Yasuhiko Tomino
Journal: Am J Pathol Date: 2012-08-05 Impact factor: 4.307

IgA nephropathy: recent developments.

Review 1. Progress in molecular and genetic studies of IgA nephropathy.

2. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.

3. High-dose intravenous immunoglobulin pulse therapy in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.

4. Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice.

5. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

6. Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy.

7. Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms.

8. End-stage renal disease secondary to IgA nephropathy in recessive dystrophic epidermolysis bullosa: a case report.

Review 9. [IgA nephropathy: frequent, but rarely diagnosed].

10. Impact of the -675 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene on childhood IgA nephropathy.